Cargando…

Uptake of COVID-19 Booster Dose among Saudi Arabian Population

Backgroundand objectives: Although several vaccines have been produced and administered around the world, new SARS-CoV-2 worsened the COVID-19 infection risk and impacted the initial vaccine dosage effectiveness. Based on studies indicating that the third and fourth COVID-19 vaccine doses significan...

Descripción completa

Detalles Bibliográficos
Autores principales: Alshahrani, Najim Z., Alsabaani, Abdullah A., Ridda, Iman, Rashid, Harunor, Alzahrani, Faris, Almutairi, Talal Hamed, Alzahrani, Bader Ahmed S., Albeshri, Abdulelah Saleh Saeed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323634/
https://www.ncbi.nlm.nih.gov/pubmed/35888690
http://dx.doi.org/10.3390/medicina58070972
_version_ 1784756600692539392
author Alshahrani, Najim Z.
Alsabaani, Abdullah A.
Ridda, Iman
Rashid, Harunor
Alzahrani, Faris
Almutairi, Talal Hamed
Alzahrani, Bader Ahmed S.
Albeshri, Abdulelah Saleh Saeed
author_facet Alshahrani, Najim Z.
Alsabaani, Abdullah A.
Ridda, Iman
Rashid, Harunor
Alzahrani, Faris
Almutairi, Talal Hamed
Alzahrani, Bader Ahmed S.
Albeshri, Abdulelah Saleh Saeed
author_sort Alshahrani, Najim Z.
collection PubMed
description Backgroundand objectives: Although several vaccines have been produced and administered around the world, new SARS-CoV-2 worsened the COVID-19 infection risk and impacted the initial vaccine dosage effectiveness. Based on studies indicating that the third and fourth COVID-19 vaccine doses significantly reduced COVID-19 transmission, Saudi Arabia has been administering COVID-19 booster vaccine doses to its citizens. The purpose of this study was to evaluate the uptake of the COVID-19 vaccine booster in relation to the socio-demographic characteristics and other associated factors among the Saudi population. Materials and Methods: This study was an online analytical cross-sectional study using a self-administered questionnaire. Pearson Chi-square test and multiple logistic regression analyses were used to determine factors associated with the uptake of COVID-19 booster dose vaccines. Results: A total of 2332 responded to our study. Overall, 527 (22.6%) participants had received a booster dose. An age of 55 and above (aOR: 5.415; 95% CI: 2.719–10.783), Eastern region (aOR: 2.513; 95% CI: 1.566–4.033), history of influenza vaccination at annual intervals (aOR: 2.387; 95% CI: 1.730–3.293), the first dose of Moderna vaccine (aOR: 1.324; 95% CI: 1.160–1.510), and cancer (aOR: 2.161; 95% CI: 1.218–3.879) were independent factors most associated with a higher uptake of the COVID-19 vaccine booster dose. In contrast, the second dose of Moderna vaccine (aOR: 0.794; 95% CI: 0.683–0.922), AstraZeneca vaccine (aOR: 0.691; 95% CI: 0.509–0.939), strong symptoms from side effects after the second dose of the COVID-19 vaccine (aOR: 0.615; 95% CI: 0.404–0.935) were independent factors most associated with a lower uptake of the COVID-19 vaccine booster dose. Conclusions: Our findings indicate low COVID-19 vaccine booster uptake. This necessitates the need for strategies to address discouraging factors of the COVID-19 vaccine booster dose uptake and engage the Saudi population to raise awareness about the importance of the booster dose.
format Online
Article
Text
id pubmed-9323634
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-93236342022-07-27 Uptake of COVID-19 Booster Dose among Saudi Arabian Population Alshahrani, Najim Z. Alsabaani, Abdullah A. Ridda, Iman Rashid, Harunor Alzahrani, Faris Almutairi, Talal Hamed Alzahrani, Bader Ahmed S. Albeshri, Abdulelah Saleh Saeed Medicina (Kaunas) Article Backgroundand objectives: Although several vaccines have been produced and administered around the world, new SARS-CoV-2 worsened the COVID-19 infection risk and impacted the initial vaccine dosage effectiveness. Based on studies indicating that the third and fourth COVID-19 vaccine doses significantly reduced COVID-19 transmission, Saudi Arabia has been administering COVID-19 booster vaccine doses to its citizens. The purpose of this study was to evaluate the uptake of the COVID-19 vaccine booster in relation to the socio-demographic characteristics and other associated factors among the Saudi population. Materials and Methods: This study was an online analytical cross-sectional study using a self-administered questionnaire. Pearson Chi-square test and multiple logistic regression analyses were used to determine factors associated with the uptake of COVID-19 booster dose vaccines. Results: A total of 2332 responded to our study. Overall, 527 (22.6%) participants had received a booster dose. An age of 55 and above (aOR: 5.415; 95% CI: 2.719–10.783), Eastern region (aOR: 2.513; 95% CI: 1.566–4.033), history of influenza vaccination at annual intervals (aOR: 2.387; 95% CI: 1.730–3.293), the first dose of Moderna vaccine (aOR: 1.324; 95% CI: 1.160–1.510), and cancer (aOR: 2.161; 95% CI: 1.218–3.879) were independent factors most associated with a higher uptake of the COVID-19 vaccine booster dose. In contrast, the second dose of Moderna vaccine (aOR: 0.794; 95% CI: 0.683–0.922), AstraZeneca vaccine (aOR: 0.691; 95% CI: 0.509–0.939), strong symptoms from side effects after the second dose of the COVID-19 vaccine (aOR: 0.615; 95% CI: 0.404–0.935) were independent factors most associated with a lower uptake of the COVID-19 vaccine booster dose. Conclusions: Our findings indicate low COVID-19 vaccine booster uptake. This necessitates the need for strategies to address discouraging factors of the COVID-19 vaccine booster dose uptake and engage the Saudi population to raise awareness about the importance of the booster dose. MDPI 2022-07-21 /pmc/articles/PMC9323634/ /pubmed/35888690 http://dx.doi.org/10.3390/medicina58070972 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Alshahrani, Najim Z.
Alsabaani, Abdullah A.
Ridda, Iman
Rashid, Harunor
Alzahrani, Faris
Almutairi, Talal Hamed
Alzahrani, Bader Ahmed S.
Albeshri, Abdulelah Saleh Saeed
Uptake of COVID-19 Booster Dose among Saudi Arabian Population
title Uptake of COVID-19 Booster Dose among Saudi Arabian Population
title_full Uptake of COVID-19 Booster Dose among Saudi Arabian Population
title_fullStr Uptake of COVID-19 Booster Dose among Saudi Arabian Population
title_full_unstemmed Uptake of COVID-19 Booster Dose among Saudi Arabian Population
title_short Uptake of COVID-19 Booster Dose among Saudi Arabian Population
title_sort uptake of covid-19 booster dose among saudi arabian population
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323634/
https://www.ncbi.nlm.nih.gov/pubmed/35888690
http://dx.doi.org/10.3390/medicina58070972
work_keys_str_mv AT alshahraninajimz uptakeofcovid19boosterdoseamongsaudiarabianpopulation
AT alsabaaniabdullaha uptakeofcovid19boosterdoseamongsaudiarabianpopulation
AT riddaiman uptakeofcovid19boosterdoseamongsaudiarabianpopulation
AT rashidharunor uptakeofcovid19boosterdoseamongsaudiarabianpopulation
AT alzahranifaris uptakeofcovid19boosterdoseamongsaudiarabianpopulation
AT almutairitalalhamed uptakeofcovid19boosterdoseamongsaudiarabianpopulation
AT alzahranibaderahmeds uptakeofcovid19boosterdoseamongsaudiarabianpopulation
AT albeshriabdulelahsalehsaeed uptakeofcovid19boosterdoseamongsaudiarabianpopulation